Eaton Vance Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.56M | Hold |
237,155
| – | – | ﹤0.01% | 978 |
|
|
2022
Q2 | $2.7M | Hold |
237,155
| – | – | ﹤0.01% | 984 |
|
|
2022
Q1 | $2.16M | Hold |
237,155
| – | – | ﹤0.01% | 1156 |
|
|
2021
Q4 | $3.54M | Hold |
237,155
| – | – | ﹤0.01% | 875 |
|
|
2021
Q3 | $6.1M | Hold |
237,155
| – | – | 0.01% | 677 |
|
|
2021
Q2 | $6.19M | Sell |
237,155
-198
| -0.1% | -$5.16K | 0.01% | 719 |
|
|
2021
Q1 | $8.38M | Buy |
237,353
+198
| +0.1% | +$6.99K | 0.01% | 599 |
|
|
2020
Q4 | $5.99M | Hold |
237,155
| – | – | 0.01% | 654 |
|
|
2020
Q3 | $8.94M | Hold |
237,155
| – | – | 0.02% | 502 |
|
|
2020
Q2 | $10.2M | Hold |
237,155
| – | – | 0.02% | 452 |
|
|
2020
Q1 | $4.61M | Buy |
+237,155
| New | +$4.61M | 0.01% | 563 |
|